| High effectiveness of platinum (IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro A Kozubík, V Horváth, L Švihálková-Šindlerová, K Souček, J Hofmanová, ... Biochemical pharmacology 69 (3), 373-383, 2005 | 85 | 2005 |
| Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin J Mikeš, J Kleban, V Sačková, V Horváth, E Jamborová, A Vaculová, ... Photochemical & Photobiological Sciences 6 (7), 758-766, 2007 | 61 | 2007 |
| New platinum (IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell … J Turánek, A Kašná, D Záluská, J Neca, V Kvardová, P Knötigová, ... Anti-Cancer Drugs 15 (5), 537-543, 2004 | 58 | 2004 |
| Glass buildings as bird feeders: urban birds exploit insects trapped by polarized light pollution B Robertson, G Kriska, V Horvath, G Horvath Acta Zoologica Academiae Scientiarum Hungaricae 56 (3), 283-293, 2010 | 50 | 2010 |
| Cisplatin and a potent platinum (IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic … O Vondálová Blanářová, I Jelínková, Á Szöőr, B Skender, K Souček, ... Carcinogenesis 32 (1), 42-51, 2011 | 49 | 2011 |
| Platinum (IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells V Horváth, O Blanářová, L Švihálková-Šindlerová, K Souček, ... Gynecologic Oncology 102 (1), 32-40, 2006 | 49 | 2006 |
| Lineage specific composition of cyclin D–CDK4/CDK6–p27 complexes reveals distinct functions of CDK4, CDK6 and individual D‐type cyclins in differentiating cells of embryonic origin V Bryja, J Pacherník, J Vondráček, K Souček, L Čajánek, V Horváth, ... Cell Proliferation 41 (6), 875-893, 2008 | 37 | 2008 |
| Increased apoptosis in differentiating p27-deficient mouse embryonic stem cells V Bryja, J Pachernik, K Souček, V Horvath, P Dvořák, A Hampl Cellular and Molecular Life Sciences CMLS 61, 1384-1400, 2004 | 36 | 2004 |
| The energy levels of Er3+ ion in yttrium aluminum borate (YAB) single crystals I Földvári, E Beregi, R Sosa, V Horvath Optical Materials 19 (2), 241-244, 2002 | 34 | 2002 |
| Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin J Kleban, J Mikeš, V Horváth, V Sačková, J Hofmanová, A Kozubík, ... Journal of Photochemistry and Photobiology B: Biology 93 (2), 108-118, 2008 | 33 | 2008 |
| Mechanisms of effects of platinum (II) and (IV) complexes. Comparison of cisplatin and oxaliplatin with satraplatin and LA-12, new Pt (IV)-based drugs. A Minireview V Foltinová, L Švihálková Šindlerová, V Horváth, P Sova, J Hofmanova, ... Scripta Medica (BRNO) 81 (2), 105-16, 2008 | 33 | 2008 |
| Abnormal Development of Mouse Embryoid Bodies Lacking p27Kip1 Cell Cycle Regulator V Bryja, L Čajánek, J Pacherník, AC Hall, V Horváth, P Dvořák, A Hampl Stem Cells 23 (7), 965-974, 2005 | 32 | 2005 |
| Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin P Solar, V Horvath, J Kleban, J Koval, Z Solárová, A Kozubík, ... Neoplasma 54 (2), 127, 2007 | 28 | 2007 |
| Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum (IV) complex vs cisplatin V Horváth, K Souček, L Švihálková-Šindlerová, J Vondráček, O Blanářová, ... Investigational New Drugs 25, 435-443, 2007 | 27 | 2007 |
| Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin J Kleban, B Szilárdiová, J Mikeš, V Horváth, V Sačková, P Brezáni, ... Journal of Photochemistry and Photobiology B: Biology 84 (2), 79-88, 2006 | 27 | 2006 |
| Modulation of Hypericin Photodynamic Therapy by Pretreatment with 12 Various Inhibitors of Arachidonic Acid Metabolism in Colon Adenocarcinoma HT‐29 Cells J Kleban, J Mikeš, B Szilárdiová, J Kovaľ, V Sačková, P Solár, V Horváth, ... Photochemistry and photobiology 83 (5), 1174-1185, 2007 | 26 | 2007 |
| Laser performance of Yb:GdCa4O(BO3)3 compared to Yb:KGd(WO4)2 under diode-bar pumping JE Hellström, V Pasiskevicius, F Laurell, B Denker, B Galagan, L Ivleva, ... Laser physics 17, 1204-1208, 2007 | 25 | 2007 |
| Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis E Ondroušková, K Souček, V Horváth, J Šmarda Leukemia research 32 (4), 599-609, 2008 | 20 | 2008 |
| Neural differentiation potentiated by the leukaemia inhibitory factor through STAT3 signalling in mouse embryonal carcinoma cells J Pacherník, V Horváth, L Kubala, P Dvorak, A Kozubík, A Hampl Folia Biologica 53 (5), 157-163, 2007 | 20 | 2007 |
| LA-12 overcomes confluence-dependent resistance of HT-29 colon cancer cells to Pt (II) compounds L ŠVIHÁLKOVÁ-ŠINDLEROVÁ, V Foltinova, A Vaculova, V Horvath, ... Anticancer research 30 (4), 1183-1188, 2010 | 18 | 2010 |
